Ketamine administration for acute painful sickle cell crisis: A randomized controlled trial.

Mohammed Saeed Saad Alshahrani Amal H AlSulaibikh Mohamed R ElTahanSukayna Z AlFarajLaila Perlas AsontoAbdullah A AlMulhimMurad F AlAbbadNisreen AlmaghrabyMohammed Al JumaanThamir O AlJunaidMoath N DarweeshFaisal M AlHawajAlaa M MahmoudBader K AlossaimiShaikhah K AlotaibiTalal M AlMutairiDuaa A AlSulaiman PharmDDunya AlfarajReem AlhawwasStefan D BaralKim LewisMadeleine M VerhovsekMark CrowtherGordon GuyattWaleed Alhazzaninull null

Published in: Academic emergency medicine : official journal of the Society for Academic Emergency Medicine (2021)

Early use of ketamine in adults with VOC resulted in a meaningful reduction in pain scores over a 2-h period and reduced the cumulative morphine dose in the ED with no significant drug-related side effects in the ketamine-treated group.

Keyphrases

pain management
chronic pain
drug induced
emergency department
liver failure
public health
respiratory failure
neuropathic pain
adverse drug
extracorporeal membrane oxygenation
electronic health record